William Blair acted as the exclusive financial advisor to Cardiovascular Medicine, P.C. (CVM) in connection with its sale to Webster Equity Partners. The deal signed on November 24, 2021 and closed on December 17, 2021.
Transaction Highlights
- Deep sector knowledge and key buyer relationships: CVM was attracted to William Blair’s deep domain expertise advising multi-site physician practice platforms and strong relationships with the most active and aggressive financial sponsors.
- Strategic positioning and execution excellence: William Blair worked closely with CVM management to position the company as the dominant market leader in cardiology and the ideal platform for organic and inorganic expansion as well as expansion into attractive ancillaries.
- Trust-based relationship and guidance: William Blair successfully advised CVM through each step of the process and worked in close collaboration to develop marketing materials and financial analyses, streamline due diligence, and navigate complex process dynamics.
About the Companies
Cardiovascular Medicine is a leading provider of cardiovascular services in the Quad Cities area. CVM focuses on turning life threatening heart disease into manageable chronic conditions for their patients. CVM offers comprehensive services across all cardiology needs with over 40 healthcare providers serving patients in the Quad Cities area.
Webster Equity Partners is a leading investment firm based in Waltham, Massachusetts. Since its founding in 2003, the firm has invested in more than 190 platforms and is currently investing out of a $1.5 billion fund raised in 2021. The firm targets market-leading healthcare services companies with high impact growth strategies that deliver the highest quality care and extraordinary service.
Learn more about our healthcare services investment banking expertise.